Literature DB >> 11267718

Late normalisation of uterine artery velocimetry in high risk pregnancy.

M Soregaroli1, A Valcamonico, L Scalvi, L Danti, T Frusca.   

Abstract

OBJECTIVE: To test whether late normalisation of abnormal uterine velocimetry is a favourable prognostic factor in high risk pregnancies. STUDY
DESIGN: Uterine artery colour Doppler velocimetry was performed at 24, 28-30 and 32-34 weeks in 282 high risk pregnancies treated with low dose aspirin.
RESULTS: 88 patients had abnormal waveforms at 24 weeks and 77 delivered after the second assessment at 28 weeks. Of these, 38 (49%) had a normalisation of Doppler indices by 34 weeks. Compared with the persistently abnormal Doppler group, these patients delivered fewer small for gestational age babies (5/38 versus 26/39; p=0.0001) and had less gestational hypertension without proteinuria (3/38 versus 15/39; p=0.004). No patients with preeclampsia or other severe complications of pregnancy were observed in the normalised group.
CONCLUSIONS: Although abnormal uterine artery velocimetry at 24 weeks is predictive of adverse pregnancy outcome, nearly half have late normalisation of the Doppler indices and a better perinatal outcome. Persistently abnormal waveforms are related to the worst pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267718     DOI: 10.1016/s0301-2115(00)00358-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Adi Tarca; Juan Pedro Kusanovic; Pooja Mittal; Sun Kwon Kim; Francesca Gotsch; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Percy Pacora; Giovanna Ogge; Zhong Dong; Chong Jai Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

2.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.

Authors:  Marzieh Vahid Dastjerdi; Sayedehafagh Hosseini; Leila Bayani
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

Review 3.  A Review of Roles of Uterine Artery Doppler in Pregnancy Complications.

Authors:  Yingying Tian; Xiuhua Yang
Journal:  Front Med (Lausanne)       Date:  2022-03-03

4.  Antenatal testing-a reevaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop.

Authors:  Caroline Signore; Roger K Freeman; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623

5.  Sildenafil citrate in fetal growth restriction.

Authors:  Subrat Panda; Ananya Das; Hossain Md Nowroz
Journal:  J Reprod Infertil       Date:  2014-07

6.  Sildenafil citrate for the management of fetal growth restriction and oligohydramnios.

Authors:  Rana Choudhary; Kavita Desai; Hetal Parekh; Kedar Ganla
Journal:  Int J Womens Health       Date:  2016-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.